title: Anaplastic astrocytoma.
abstract: Standard treatment of anaplastic astrocytoma (AA) in good performance patients consists of maximal safe surgical resection followed by focal, fractionated, external beam radiotherapy (RT) alone or in combination with concurrent and adjuvant temozolomide (TMZ). Since prospective data regarding the use of chemoradiotherapy for AA is lacking, the practice is based on the extrapolation of results from a randomized study in glioblastoma (GB). Whether the data from the GB study can and should be extrapolated is controversial, although a large multicenter, randomized, phase III study is underway to define optimal initial AA treatment. Patients should be tapered off corticosteroids completely or to the lowest dose necessary to treat neurologic dysfunction. Anti-epileptic drugs (AED) are not indicated unless there is a history of seizure; levetiracetam is the preferred AED in malignant glioma (MG). Unless there is evidence of intracranial hemorrhage, venous thromboembolism (VTE) should be treated with low-molecular-weight heparin (LMWH) therapy. At recurrence, patients with good performance status are usually treated with cytotoxic chemotherapy following, or in lieu of, repeat surgery. TMZ is the preferred chemotherapeutic agent in patients without prior exposure; lomustine is recommended for tumors resistant to TMZ. In patients with neurologic dysfunction secondary to tumor edema and mass effect who are not amenable to surgery, the use of bevacizumab is associated with improved neurologic function and better quality of life. Given the limited treatment options at tumor recurrence, consideration for enrollment on a clinical trial is encouraged.
authors.affiliation: Department of Neurology, University of Minnesota School of Medicine, 420 Delaware Street SE, MMC 295, Minneapolis, MN, 55455, USA, sgrimm@umn.edu.
authors.forename: Sean A
authors.initials: SA
authors.lastname: Grimm
authors.forename: Thomas J
authors.initials: TJ
authors.lastname: Pfiffner
references.citation: Br Med J. 1973 Dec 1;4(5891):523-5
references.pmid: 4519011
references.citation: Eur J Cancer. 1997 Sep;33(10):1592-6
references.pmid: 9389920
references.citation: N Engl J Med. 2000 Nov 9;343(19):1350-4
references.pmid: 11070098
references.citation: Nature. 2009 Dec 10;462(7274):739-44
references.pmid: 19935646
references.citation: J Neurooncol. 2012 Dec;110(3):325-33
references.pmid: 23015095
references.citation: Cancer Cell. 2006 Mar;9(3):157-73
references.pmid: 16530701
references.citation: Drug Metab Dispos. 1999 Feb;27(2):250-4
references.pmid: 9929511
references.citation: Lancet Oncol. 2008 May;9(5):453-61
references.pmid: 18452856
references.citation: J Neurol. 1998 Nov;245(11):695-708
references.pmid: 9808237
references.citation: J Clin Oncol. 2010 Apr 20;28(12):2051-7
references.pmid: 20308655
references.citation: Crit Rev Oncol Hematol. 2007 Jul;63(1):72-80
references.pmid: 17478095
references.citation: Int J Radiat Oncol Biol Phys. 1979 Oct;5(10):1733-40
references.pmid: 231023
references.citation: Lancet Neurol. 2007 May;6(5):421-30
references.pmid: 17434097
references.citation: Neurology. 2000 May 23;54(10):1886-93
references.pmid: 10822423
references.citation: J Neurosurg. 1989 Jul;71(1):1-9
references.pmid: 2661738
references.citation: Int J Radiat Oncol Biol Phys. 1979 Oct;5(10):1725-31
references.pmid: 231022
references.citation: Br J Neurosurg. 2007 Dec;21(6):550-61
references.pmid: 18071982
references.citation: Lancet. 2003 Jan 25;361(9354):323-31
references.pmid: 12559880
references.citation: Science. 2008 Sep 26;321(5897):1807-12
references.pmid: 18772396
references.citation: J Neuropathol Exp Neurol. 1993 Nov;52(6):609-18
references.pmid: 8229080
references.citation: Int J Radiat Oncol Biol Phys. 1989 Jun;16(6):1405-9
references.pmid: 2542195
references.citation: N Engl J Med. 2005 Mar 10;352(10):997-1003
references.pmid: 15758010
references.citation: Indian J Cancer. 2009 Apr-Jun;46(2):108-19
references.pmid: 19346644
references.citation: Acta Neuropathol. 2007 Aug;114(2):97-109
references.pmid: 17618441
references.citation: Neuro Oncol. 2012 Sep;14 Suppl 4:iv73-80
references.pmid: 23095833
references.citation: Neurology. 2007 Feb 6;68(6):402-8
references.pmid: 17283312
references.citation: Clin Cancer Res. 2004 Dec 15;10(24):8220-8
references.pmid: 15623597
references.citation: J Neurosurg. 1979 May;50(5):624-8
references.pmid: 430157
references.citation: Acta Radiol Oncol Radiat Phys Biol. 1978;17(6):475-84
references.pmid: 216238
references.citation: Eur Radiol. 2010 Mar;20(3):704-13
references.pmid: 19763581
references.citation: J Neurooncol. 2012 Jan;106(1):121-5
references.pmid: 21706358
references.citation: J Clin Oncol. 2009 Dec 10;27(35):5874-80
references.pmid: 19901110
references.citation: Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):71-7
references.pmid: 11163499
references.citation: J Neurooncol. 2006 May;77(3):297-303
references.pmid: 16314945
references.citation: Genes Dev. 2007 Nov 1;21(21):2683-710
references.pmid: 17974913
references.citation: J Neurooncol. 2011 Aug;104(1):253-9
references.pmid: 21153680
references.citation: Lancet. 2002 Nov 2;360(9343):1361-8
references.pmid: 12423981
references.citation: Lancet Oncol. 2012 Jul;13(7):707-15
references.pmid: 22578793
references.citation: J Natl Cancer Inst. 1987 Aug;79(2):233-8
references.pmid: 3474455
references.citation: J Clin Oncol. 2010 Jun 20;28(18):3048-53
references.pmid: 20479391
references.citation: Surg Neurol Int. 2012;3(Suppl 4):S320-7
references.pmid: 23230537
references.citation: Curr Neurol Neurosci Rep. 2011 Jun;11(3):291-7
references.pmid: 21465149
references.citation: Acta Neuropathol. 2010 Apr;119(4):487-94
references.pmid: 20127344
references.citation: Neurol Clin. 2009 Feb;27(1):171-201, ix
references.pmid: 19055979
references.citation: J Exp Clin Cancer Res. 1998 Dec;17(4):479-82
references.pmid: 10089071
references.citation: Int J Radiat Oncol Biol Phys. 1992;23(1):3-8
references.pmid: 1572829
references.citation: Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):835-41
references.pmid: 20472350
references.citation: Lancet Oncol. 2005 Mar;6(3):167-75
references.pmid: 15737833
references.citation: Int J Radiat Oncol Biol Phys. 1982 Oct;8(10):1787-94
references.pmid: 6295986
references.citation: J Clin Pathol. 2011 Oct;64(10):835-44
references.pmid: 21752797
references.citation: Lancet Oncol. 2011 Oct;12(11):997-1003
references.pmid: 21868284
references.citation: Acta Neuropathol. 2010 Dec;120(6):707-18
references.pmid: 21088844
references.citation: Curr Treat Options Neurol. 2010 Jul;12(4):321-33
references.pmid: 20842591
references.citation: Curr Treat Options Oncol. 2011 Sep;12(3):240-52
references.pmid: 21594589
references.citation: Neuro Oncol. 2011 Oct;13(10):1143-50
references.pmid: 21865400
references.citation: Scand J Work Environ Health. 1987 Oct;13(5):417-23
references.pmid: 2829348
references.citation: Neuro Oncol. 2012 Nov;14 Suppl 5:v1-49
references.pmid: 23095881
references.citation: Br J Radiol. 2011 Dec;84 Spec No 2:S90-106
references.pmid: 22433833
references.citation: Lancet. 2002 Mar 23;359(9311):1011-8
references.pmid: 11937180
references.citation: Curr Opin Neurol. 2011 Dec;24(6):648-52
references.pmid: 22002076
references.citation: J Clin Oncol. 1999 Sep;17(9):2762-71
references.pmid: 10561351
references.citation: Neurology. 1980 Sep;30(9):907-11
references.pmid: 6252514
references.citation: Nature. 2008 Oct 23;455(7216):1061-8
references.pmid: 18772890
references.citation: Clin Cancer Res. 2008 Nov 1;14(21):7068-73
references.pmid: 18981004
references.citation: J Neurosurg. 1978 Sep;49(3):333-43
references.pmid: 355604
references.citation: Neurology. 1993 Jun;43(6):1111-4
references.pmid: 8170553
references.citation: J Thromb Haemost. 2010 Sep;8(9):1959-65
references.pmid: 20598077
references.citation: N Engl J Med. 2009 Feb 19;360(8):765-73
references.pmid: 19228619
references.citation: J Neurooncol. 2012 Nov;110(2):227-35
references.pmid: 22875708
references.citation: N Engl J Med. 2003 Jul 10;349(2):146-53
references.pmid: 12853587
references.citation: Br J Cancer. 1992 Aug;66(2):373-85
references.pmid: 1503912
references.citation: J Clin Oncol. 2008 May 1;26(13):2192-7
references.pmid: 18445844
references.citation: Acta Neuropathol. 1994;87(1):47-54
references.pmid: 7511316
references.citation: N Engl J Med. 2005 Mar 10;352(10):987-96
references.pmid: 15758009
references.citation: Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):47-55
references.pmid: 16111571
references.citation: Neuro Oncol. 2009 Jun;11(3):242-9
references.pmid: 19234232
references.citation: Am J Ind Med. 1994 Aug;26(2):155-69
references.pmid: 7977393